The Evelyn F. and William L. McKnight Brain Institute at the University of Florida is a comprehensive and diverse neuroscience research center that houses the UF College of Medicine’s four “neuro” departments: neuroscience, neurology, neurosurgery and psychiatry.

During the past decade, University of Florida McKnight Brain Institute conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 6 clinical trials were completed, i.e. on average, 46.2% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 5 clinical trials were completed. i.e. 83.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Florida McKnight Brain Institute" #1 sponsor was "University of Florida" with 10 trials, followed by "Helixmith Co., Ltd." with 2 trials sponsored, "Marinus Pharmaceuticals" with 2 trials sponsored, "Diffusion Pharmaceuticals Inc" with 1 trials sponsored and "Ipsen" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Florida McKnight Brain Institute" #1 collaborator was "National Institute on Aging (NIA)" with 4 trials as a collaborator, "University of Arizona" with 2 trials as a collaborator, "Facial Pain Research Foundation" with 1 trials as a collaborator, "Monteris Medical" with 1 trials as a collaborator and "National Foliage Foundation" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "University of Florida McKnight Brain Institute" are "Aging" (2 trials), "Diabetic Neuropathy, Painful" (2 trials), "Painful Diabetic Neuropathy" (2 trials), "Alzheimer Disease, Protection Against" (1 trials) and "Amyotrophic Lateral Sclerosis" (1 trials). Many other conditions were trialed in "University of Florida McKnight Brain Institute" in a lesser frequency.

Most popular intervention types in "University of Florida McKnight Brain Institute" are "Drug" (6 trials), "Device" (5 trials), "Other" (5 trials), "Behavioral" (3 trials) and "Biological" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Acthar" (1 trials), "Active NIR-PBM" (1 trials), "Bevacizumab" (1 trials) and "Botulinum toxin type A" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of Florida McKnight Brain Institute" are 16 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "University of Florida McKnight Brain Institute". undefined are not yet recruiting, 4 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in University of Florida McKnight Brain Institute, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in University of Florida McKnight Brain Institute, 2 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 7 trials that are defined as “Not Applicable".